Personal information

Switzerland

Activities

Employment (3)

Institute of Oncology Research: Bellinzona, Ticino, CH

2018-01-01 to present | Head of Bioinformatics Core Unit
Employment
Source: Self-asserted source
Luciano Cascione

Institute of Oncology Research: Bellinzona, CH

2013-03-19 to 2018-01-01 | PostDoc- Junior Bioinformatician (Lymphoma Research Group)
Employment
Source: Self-asserted source
Luciano Cascione

Università degli Studi di Catania: Catania, Sicilia, IT

2009-10-01 to 2012-10-01 | Phd Student (Facolta' di Medicina e Chirurgia)
Employment
Source: Self-asserted source
Luciano Cascione

Education and qualifications (3)

University of Catania: Catania, Sicilia, IT

2009-09-01 to 2012-10-01 | Ph.D in Bioinformatics
Education
Source: Self-asserted source
Luciano Cascione

University of Catania: Catania, IT

2006-09-01 to 2009-07-01 | Master of Computer Science (Mathematics and Computer Science)
Education
Source: Self-asserted source
Luciano Cascione

University of Catania: Catania, IT

2002-09-01 to 2006-04-01 | Bachelor of Computer Science (Mathematics and Informatics)
Education
Source: Self-asserted source
Luciano Cascione

Funding (2)

Ultra-conserved long non-coding RNAs in B-cell lymphoma

2019-07 to 2021-07 | Grant
Krebsliga Schweiz (Bern, CH)
GRANT_NUMBER:

KFS-4713-02-2019

Source: Self-asserted source
Luciano Cascione

Targeted agents in splenic marginal zone lymphoma: mechanisms of resistance and new combinations

2016-02-01 to 2019-01-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 163232
Source: Self-asserted source
Luciano Cascione via DimensionsWizard

Works (50 of 226)

Items per page:
Page 1 of 5

A High-Throughput Bone Marrow 3D Co-Culture System to Develop Resistance to B Cell Receptor Signaling Targeted Agents in B Cell Non-Hodgkin Lymphoma

2025-01-19 | Preprint
Contributors: Alex Zadro; Alberto Arribas; Maria Vittoria Colombo; Eleonora Cannas; Filippo Spriano; Luciano Cascione; Afua Adjeiwaa Mensah; Federico Simonetta; Dalila Petta; Chiara Arrigoni et al.
Source: check_circle
Crossref

PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

Blood Advances
2024-12-24 | Journal article
Contributors: Alberto J. Arribas; Sara Napoli; Eugenio Gaudio; Charles Herbaux; Eleonora Cannas; Chiara Tarantelli; Roberta Bordone-Pittau; Luciano Cascione; Nicolas Munz; Luca Aresu et al.
Source: check_circle
Crossref

Enhancer lncRNA LOC730338 limits the innate immune response against lymphoma cells, inhibiting ADAR2-dependent alternative transcription

2024-12-12 | Preprint
Contributors: Luciano Cascione; Francesca Guidetti; Sunandini Ramnarayanan; Andrea Rinaldi; Filippo Spriano; Alex Zadro; Chiara Tarantelli; Nicolas Munz; Alberto J. Arribas; Rory Johnson et al.
Source: check_circle
Crossref

DiGAS: Differential gene allele spectrum as a descriptor in genetic studies

Computers in Biology and Medicine
2024-09 | Journal article
Contributors: Antonino Aparo; Vincenzo Bonnici; Simone Avesani; Luciano Cascione; Rosalba Giugno
Source: check_circle
Crossref

Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

Clinical Cancer Research
2024-05-15 | Journal article
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Data from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Data from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Figure S6 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Methods S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Methods S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Tables S1-S19 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Tables S1-S19 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Video S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Video S1 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Video S2 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Supplementary Video S2 from Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652–3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer

2024-05-15 | Preprint
Contributors: Somaieh Hedayat; Luciano Cascione; David Cunningham; Marta Schirripa; Andrea Lampis; Jens C. Hahne; Nina Tunariu; Sung Pil Hong; Silvia Marchetti; Khurum Khan et al.
Source: check_circle
Crossref

Data from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Data from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

Molecular Cancer Therapeutics
2024-03-04 | Journal article
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S1 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S1 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S10 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S10 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S11 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S11 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S12 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S12 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S13 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S13 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S14 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S14 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S15 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S15 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S16 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S16 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S17 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S17 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S18 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref

Figure S18 from ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

2024-03-04 | Preprint
Contributors: Alberto J. Arribas; Sara Napoli; Luciano Cascione; Laura Barnabei; Giulio Sartori; Eleonora Cannas; Eugenio Gaudio; Chiara Tarantelli; Afua A. Mensah; Filippo Spriano et al.
Source: check_circle
Crossref
Items per page:
Page 1 of 5

Peer review (1 review for 1 publication/grant)

Review activity for Breast cancer research (1)